Marcos Cortes

Managing Director
30+ years of consulting experience with 14 years in M&A strategy
Expert in M&A regulatory compliance and pharmaceutical management
Has led major transactions, including a $63 billion pharma integration, $31 billion spin-off, and $4 billion divestiture
Miami
@alvarezmarsal
LinkedIn
Copied!
Marcos Cortes is a Managing Director with Alvarez & Marsal Corporate Transactions in Miami. With three decades of consulting experience, he has specialized in mergers and acquisitions (M&A) strategy for the last 14 years. Focusing on life sciences and industrials, Mr. Cortes has deep experience in pharmaceutical management, policy, and outcomes.

Mr. Cortes assists corporate clients with executing inorganic and organic growth strategies. He manages initiatives related to mergers, acquisitions, and carve-outs from due diligence to post-closing activities. Mr. Cortes brings extensive experience in M&A gross-to-net transitions and antitrust M&A regulation, leveraging his knowledge to help clients navigate complex regulatory environments with ease. 

Working across Europe, the Americas, and Asia, his notable engagements include: leading a $63 billion integration of a Fortune 100 research-based global biopharmaceutical company with a global pharma company; advising on a $31 billion tax-free spin for a medical device division of a global pharmaceutical company; and directing a $4 billion divestiture of a business unit for a Fortune 500 technology multinational based in California. 

Mr. Cortes designed a comprehensive product database called the Deal Product Perimeter that captures and offers an in-depth understanding of assets under review. He also orchestrated strategic due diligence for a market-leading diabetes and obesity biopharmaceutical corporation which acquired a biopharmaceutical company’s manufacturing arm and integrated 400 specialists, and he advised a $1 billion complex divestment for a large multinational pharmaceutical company.

Prior to joining A&M, Mr. Cortes was part of the KPMG M&A Strategy team advising global clients on due diligence and pre- and post-merger activities. He also formed and led a strategic global cross-functional internal M&A organization at Siemens. 

Mr. Cortes earned a bachelor’s degree in engineering from Universidade Cruzeiro do Sul, Brazil and an MBA (concentration in entrepreneurship) from the Crummer Graduate School of Business at Rollins College, Florida. He earned a certificate from the advanced M&A strategy program at the University of California Los Angeles, a certificate in pharmaceutical management from Cornell University, and a master’s degree in pharmaceutical sciences (concentration in pharmaceutical regulation) from the University of Florida. Mr. Cortes is also a Certified Project Management Professional (PMP).

Insights By This Professional

A&M's AI Agent empowers M&A deal-makers to analyze and extract actionable insights from voluminous datasets, and also streamline the sign-to-close process.
This episode highlights how A&M Assist leverages AI-driven tools and A&M’s deep industry expertise to help dealmakers achieve transaction goals with unmatched speed and precision.
The JP Morgan Healthcare Conference 2025 offered a comprehensive view of the transformative trends, challenges, and opportunities shaping the biopharma and healthcare landscape. From AI to innovative biotechs, we explore the key takeaways and offer insights into how stakeholders can leverage these developments for success.
Alvarez & Marsal is proud to release the 2024 2024 Biotechnology M&A and Venture Capital Highlights Report.
Latest insights The latest insights from Marcos Cortes's team
Thought Leadership
A&M's AI Agent empowers M&A deal-makers to analyze and extract actionable insights from voluminous datasets, and also streamline the sign-to-close process.
Contact me
FOLLOW & CONNECT WITH A&M